ArticleRSC chemical biology2026
Precursor gene engineering expands the loop region of the lasso peptide microcin J25.
Article in RSC chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microcin J25 (MccJ25) is the prototypical member of the lasso peptide family and is characterized by a mechanically interlocked structure. Scientists have long been interested in MccJ25 for its potent RNA polymerase inhibitory activity and unique threaded topology. Previous efforts to generate MccJ25 variants through precursor engineering have largely focused on amino acid substitutions - many of which were poorly tolerated by the biosynthetic machinery and resulted in diminished production. In this work, we demonstrated that the MccJ25 biosynthetic enzymes are surprisingly permissive toward insertions in the loop region. Specifically, the loop can be expanded at different positions by up to 15 additional amino acids and accommodate diverse types of amino acids. Our findings suggest that the lasso synthetase (McjC) has a sizable cavity that tolerates loop expansions. More broadly, this work establishes a new strategy for constructing mechanically interlocked molecules and potentially enables the grafting of diverse bioactive ligands onto the MccJ25 scaffold.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.